Hospital
Delta Health System
Delta Health System was paid $8.29M by Medicaid between Feb 2021 and Jan 2024, across 165 billing codes. Its largest line is 99284, emergency room visit (serious) — 17% of everything it billed.
33Billing provider infoDELTA HEALTH SYSTEM
CLARKSDALE, MS 38614
CLARKSDALE, MS 38614
33aNPI1740876382assigned 12/17/2020
33bProvider typeGeneral Acute Care Hospital
28Total paid$8.29M
24GClaims278,121
24DCodes billed165
24AFirst – last monthFeb 2021 – Jan 2024
Compared with peers
Next to other General Acute Care Hospital providers in Mississippi
Rank by total paid#38 of 77
Median peer was paid$8.23M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 96,693 | $2.54M | |
| 2022 | 95,876 | $2.50M | |
| 2023 | 79,751 | $3.03M | |
| 2024incomplete | 5,801 | $228K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 17% | 9,211 | 6,669 | $1.38M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 15% | 11,101 | 7,955 | $1.23M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.8% | 4,765 | 3,321 | $812K |
| G0378 | Hospital observation service, per hour | 8.3% | 3,098 | 1,806 | $690K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.5% | 4,174 | 2,792 | $294K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 3.0% | 7,904 | 5,090 | $251K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.9% | 4,182 | 2,190 | $241K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.4% | 2,795 | 1,823 | $195K |
| 71045 | Radiologic examination, chest; single view | 2.2% | 5,484 | 3,773 | $184K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.1% | 7,125 | 5,274 | $173K |
| 59025 | Fetal non-stress test | 1.7% | 1,482 | 791 | $141K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.6% | 1,674 | 1,001 | $134K |
153 more codes
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1.4% | 2,144 | $120K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 1.4% | 1,944 | $113K |
| 86900 | 1.1% | 1,972 | $94K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.1% | 1,202 | $92K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.1% | 669 | $90K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 2,209 | $88K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.0% | 668 | $86K |
| 80053 | Comprehensive metabolic panel | 1.0% | 16,040 | $85K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,104 | $83K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 2,180 | $83K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 6,725 | $82K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,095 | $81K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,706 | $79K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,801 | $78K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 1,158 | $75K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,343 | $74K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,246 | $72K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,249 | $67K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 3,783 | $65K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 782 | $47K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 195 | $39K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 713 | $39K |
| 83880 | <1% | 2,497 | $38K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 9,671 | $34K |
| 82731 | <1% | 891 | $34K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 714 | $34K |
| 85027 | <1% | 10,249 | $32K | |
| 76830 | Ultrasound, transvaginal | <1% | 585 | $31K |
| 86901 | <1% | 1,970 | $28K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 13,702 | $27K |
| 84484 | <1% | 4,359 | $26K | |
| 86850 | <1% | 1,411 | $26K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 469 | $25K |
| 87430 | <1% | 2,061 | $23K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,442 | $22K |
| 80306 | <1% | 2,271 | $22K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 371 | $21K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,372 | $20K |
| 73030 | <1% | 649 | $18K | |
| 76818 | <1% | 310 | $18K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,909 | $16K |
| G0379 | Direct admission of patient for hospital observation care | <1% | 510 | $16K |
| 73560 | <1% | 492 | $16K | |
| 84703 | <1% | 3,526 | $15K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,456 | $13K |
| 83735 | <1% | 4,497 | $13K | |
| 74018 | <1% | 374 | $13K | |
| 81001 | <1% | 7,769 | $12K | |
| 73562 | <1% | 306 | $11K | |
| 73610 | <1% | 284 | $11K | |
| 84702 | <1% | 1,100 | $10K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,923 | $10K |
| 73630 | <1% | 307 | $10K | |
| 73130 | <1% | 211 | $9K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 125 | $8K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 250 | $8K |
| 83690 | <1% | 2,533 | $8K | |
| 85730 | <1% | 2,827 | $8K | |
| 36430 | <1% | 105 | $8K | |
| 87420 | <1% | 772 | $7K | |
| 80061 | Lipid panel | <1% | 1,045 | $7K |
| 87040 | <1% | 1,267 | $7K | |
| 85610 | <1% | 3,249 | $7K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 106 | $7K |
| 97035 | <1% | 1,016 | $6K | |
| 87210 | <1% | 2,248 | $6K | |
| 83605 | <1% | 1,080 | $5K | |
| 82962 | <1% | 3,192 | $5K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 232 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,257 | $5K |
| 85384 | <1% | 766 | $5K | |
| 71250 | <1% | 200 | $4K | |
| 82607 | <1% | 544 | $4K | |
| 94060 | <1% | 117 | $4K | |
| 81003 | <1% | 3,264 | $4K | |
| 82570 | <1% | 1,311 | $4K | |
| 82805 | <1% | 128 | $3K | |
| 93925 | <1% | 60 | $3K | |
| 94726 | <1% | 102 | $3K | |
| 80069 | <1% | 832 | $3K | |
| 73502 | <1% | 118 | $3K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 41 | $3K |
| 84156 | <1% | 1,397 | $2K | |
| J3490 | Unclassified drugs | <1% | 3,856 | $2K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 231 | $2K |
| 85379 | <1% | 439 | $2K | |
| 36600 | <1% | 48 | $2K | |
| 84439 | <1% | 341 | $2K | |
| 51702 | <1% | 55 | $2K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 28 | $2K |
| 86140 | <1% | 416 | $1K | |
| 97161 | <1% | 31 | $1K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 39 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,551 | $1K |
| 97162 | <1% | 39 | $782.02 | |
| 76642 | <1% | 39 | $776.64 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 30 | $677.41 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 30 | $672.79 |
| 87070 | <1% | 155 | $651.26 | |
| 82150 | <1% | 165 | $520.42 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 1,345 | $437.65 |
| 82077 | <1% | 44 | $430.17 | |
| 87186 | <1% | 78 | $425.67 | |
| 85651 | <1% | 154 | $387.68 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,399 | $336.65 |
| 97033 | <1% | 56 | $297.43 | |
| 82550 | <1% | 52 | $195.80 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 857 | $191.29 |
| 86592 | <1% | 74 | $170.51 | |
| 82951 | <1% | 16 | $161.44 | |
| 87077 | <1% | 19 | $152.02 | |
| 87205 | <1% | 67 | $141.62 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,860 | $111.02 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,455 | $104.18 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,776 | $76.81 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 54 | $71.56 |
| 82247 | <1% | 20 | $64.77 | |
| 82947 | <1% | 12 | $50.78 | |
| 82952 | <1% | 16 | $47.42 | |
| 82565 | <1% | 16 | $42.81 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 100 | $41.56 |
| 82009 | <1% | 17 | $20.23 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,196 | $18.23 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 1,141 | $17.89 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 294 | $12.14 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 980 | $3.36 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 678 | $3.10 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,401 | $1.84 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 54 | $0.71 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 769 | $0.62 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,121 | $0.16 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 495 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 1,072 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 392 | $0.00 |
| 96376 | 0% | 1,516 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 103 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 145 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 45 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 1,422 | $0.00 |
| 84145 | 0% | 183 | $0.00 | |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 91 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 588 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 102 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 530 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 122 | $0.00 |
| 90715 | 0% | 151 | $0.00 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 0% | 272 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 135 | $0.00 |
| J7510 | Prednisolone oral, per 5 mg | 0% | 187 | $0.00 |
| J0595 | Injection, butorphanol tartrate, 1 mg | 0% | 60 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 86 | $0.00 |
| J1953 | Injection, levetiracetam, 10 mg | 0% | 21 | $0.00 |
| J3105 | Injection, terbutaline sulfate, up to 1 mg | 0% | 24 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTACKER, IRIS (CEO)
Parent organizationDELTA HEALTH-THE MEDICAL CENTER
| Provider | Location | Paid |
|---|---|---|
| Delta Health System | Greenville, MS | $39.05M |
| Delta Medical Group | Greenville, MS | $7.40M |
| Delta Health System | Greenville, MS | $6.57M |
| Delta Health System | Greenville, MS | $4.30M |
| Delta Health System | Clarksdale, MS | $366K |
| Delta Health System | Greenville, MS | $114K |
| Delta Health System | Greenville, MS | $5K |
| Delta Health System | Clarksdale, MS | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.